135 related articles for article (PubMed ID: 25686113)
41. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
42. Tumor Microenvironment in Gene Signatures: Critical Biology or Confounding Noise?
Morris JS; Kopetz S
Clin Cancer Res; 2016 Aug; 22(16):3989-91. PubMed ID: 27334836
[TBL] [Abstract][Full Text] [Related]
43. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
[TBL] [Abstract][Full Text] [Related]
44. Tumour endothelial cells acquire drug resistance in a tumour microenvironment.
Hida K; Akiyama K; Ohga N; Maishi N; Hida Y
J Biochem; 2013 Mar; 153(3):243-9. PubMed ID: 23293323
[TBL] [Abstract][Full Text] [Related]
45. Application of single-cell technology in cancer research.
Liang SB; Fu LW
Biotechnol Adv; 2017 Jul; 35(4):443-449. PubMed ID: 28390874
[TBL] [Abstract][Full Text] [Related]
46. A look at the origins of cancer epigenetics.
Cancer Discov; 2013 Jul; 3(7):713. PubMed ID: 23847337
[TBL] [Abstract][Full Text] [Related]
47. Cancer-related networks: a help to understand, predict and change malignant transformation.
Csermely P; Korcsmáros T
Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
[TBL] [Abstract][Full Text] [Related]
48. Taming the cancer cell.
Jernberg Wiklund H; Westermark B
J Intern Med; 2014 Jul; 276(1):2-4. PubMed ID: 24943457
[No Abstract] [Full Text] [Related]
49. CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.
Shi J; Wei Y; Xia J; Wang S; Wu J; Chen F; Huang G; Chen J
Future Oncol; 2014 Apr; 10(5):749-59. PubMed ID: 24799056
[TBL] [Abstract][Full Text] [Related]
50. [Immunology and personalized medicine in oncology].
Zinzindohoué F; Zeitoun G; Berger A; Todosi AM; Marliot F; Lagorce C; Galon J; Pagès F
Bull Cancer; 2014 Jun; 101 Suppl 1():S12-7. PubMed ID: 24966077
[TBL] [Abstract][Full Text] [Related]
51. Inflammation and cancer stem cells.
Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
[TBL] [Abstract][Full Text] [Related]
52. Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.
Welch DR
Cancer Res; 2016 Jan; 76(1):4-6. PubMed ID: 26729788
[TBL] [Abstract][Full Text] [Related]
53. Targeted therapies of solid cancers: new options, new challenges.
Awada A; Aftimos PG
Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
[TBL] [Abstract][Full Text] [Related]
54. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.
Galon J; Angell HK; Bedognetti D; Marincola FM
Immunity; 2013 Jul; 39(1):11-26. PubMed ID: 23890060
[TBL] [Abstract][Full Text] [Related]
55. Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas.
Francis P; Fernebro J; Edén P; Laurell A; Rydholm A; Domanski HA; Breslin T; Hegardt C; Borg A; Nilbert M
Genes Chromosomes Cancer; 2005 Jul; 43(3):302-8. PubMed ID: 15834945
[TBL] [Abstract][Full Text] [Related]
56. Microbiota in Tumors: From Understanding to Application.
Xie Y; Xie F; Zhou X; Zhang L; Yang B; Huang J; Wang F; Yan H; Zeng L; Zhang L; Zhou F
Adv Sci (Weinh); 2022 Jul; 9(21):e2200470. PubMed ID: 35603968
[TBL] [Abstract][Full Text] [Related]
57. From the EAA conference on the TME.
Romero D
Nat Rev Clin Oncol; 2020 May; 17(5):274. PubMed ID: 32203274
[No Abstract] [Full Text] [Related]
58. Discovering intratumor heterogeneity: the next frontier for pathologists.
López JI; De Petris G
Pathologica; 2017 Jun; 109(2):110-113. PubMed ID: 28748969
[TBL] [Abstract][Full Text] [Related]
59. Preface.
Pruitt K
Prog Mol Biol Transl Sci; 2016; 144():xiii. PubMed ID: 27865470
[No Abstract] [Full Text] [Related]
60. Neutrophils are shaped by the tumor microenvironment: novel possibilities for targeting neutrophils in cancer.
Silvestre-Roig C; Kalafati L; Chavakis T
Signal Transduct Target Ther; 2024 Apr; 9(1):77. PubMed ID: 38565899
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
